Report Summary
Eternity Insights has published a new study on Global Ion Channel Modulators Market focusing on key segments as by Type (Channel Blockers, Channel Openers, Other), by Application (Clinical Trials, Hospital, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Ion Channel Modulators Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Ion Channel Modulators Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Ion Channel Modulators Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Ion Channel Modulators Market Segmentation:
Ion Channel Modulators Market, By Type
- Channel Blockers
- Channel Openers
- Other
Ion Channel Modulators Market, By Application
- Clinical Trials
- Hospital
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Ion Channel Modulators market in terms of demand generation. The Ion Channel Modulators market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Ion Channel Modulators market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Ion Channel Modulators Market Taxonomy:
To learn more about this report
Global Ion Channel Modulators Market Competitive Landscape
The global Ion Channel Modulators market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Pfizer
- Inc.
- Neusentis
- Inc.
- AstraZeneca
- Aurora Biomed
- Inc.
- CalciMedica
- Inc.
- Cellectricon AB
- Convergence Pharmaceuticals Limited
- Cytocentrics AG
- Evotec AG
- Flyion GmbH
- GlaxoSmithKline Plc.
- Nanion Technologies GmbH
- NeuroSearch A/S
- Novartis AG
- Parion Sciences
- Inc.
- Sanofi
- Targacept
- Inc.
- Xention Limited
- Zalicus
- Inc.
- Others
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Channel Blockers, Channel Openers, Other |
| By Application Outlook |
Clinical Trials, Hospital, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Pfizer, Inc., Neusentis, Inc., AstraZeneca, Aurora Biomed, Inc., CalciMedica, Inc., Cellectricon AB, Convergence Pharmaceuticals Limited, Cytocentrics AG, Evotec AG, Flyion GmbH, GlaxoSmithKline Plc., Nanion Technologies GmbH, NeuroSearch A/S, Novartis AG, Parion Sciences, Inc., Sanofi, Targacept, Inc., Xention Limited, Zalicus, Inc., Others |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Ion Channel Modulators Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Ion Channel Modulators Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Channel Blockers Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Channel Openers Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Ion Channel Modulators Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Ion Channel Modulators Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Ion Channel Modulators Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Ion Channel Modulators Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Ion Channel Modulators Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Ion Channel Modulators Market Assessment by Type
8.1 Asia Pacific Ion Channel Modulators Market Assessment by Application (Consumption and Market Share)
8.2 North America Ion Channel Modulators Market Assessment by Application (Consumption and Market Share)
8.3 Europe Ion Channel Modulators Market Assessment by Application (Consumption and Market Share)
8.4 South America Ion Channel Modulators Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Ion Channel Modulators Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Pfizer, Inc.
9.1.1 Pfizer, Inc. Profiles
9.1.2 Pfizer, Inc. Product Portfolio
9.1.3 Pfizer, Inc. Ion Channel Modulators Business Performance
9.1.4 Pfizer, Inc. Ion Channel Modulators Business Development and Market Status
9.2 Neusentis, Inc.
9.2.1 Neusentis, Inc. Profiles
9.2.2 Neusentis, Inc. Product Portfolio
9.2.3 Neusentis, Inc. Ion Channel Modulators Business Performance
9.2.4 Neusentis, Inc. Ion Channel Modulators Business Development and Market Status
9.3 AstraZeneca
9.3.1 AstraZeneca Profiles
9.3.2 AstraZeneca Product Portfolio
9.3.3 AstraZeneca Ion Channel Modulators Business Performance
9.3.4 AstraZeneca Ion Channel Modulators Business Development and Market Status
9.4 Aurora Biomed, Inc.
9.4.1 Aurora Biomed, Inc. Profiles
9.4.2 Aurora Biomed, Inc. Product Portfolio
9.4.3 Aurora Biomed, Inc. Ion Channel Modulators Business Performance
9.4.4 Aurora Biomed, Inc. Ion Channel Modulators Business Development and Market Status
9.5 CalciMedica, Inc.
9.5.1 CalciMedica, Inc. Profiles
9.5.2 CalciMedica, Inc. Product Portfolio
9.5.3 CalciMedica, Inc. Ion Channel Modulators Business Performance
9.5.4 CalciMedica, Inc. Ion Channel Modulators Business Development and Market Status
9.6 Cellectricon AB
9.6.1 Cellectricon AB Profiles
9.6.2 Cellectricon AB Product Portfolio
9.6.3 Cellectricon AB Ion Channel Modulators Business Performance
9.6.4 Cellectricon AB Ion Channel Modulators Business Development and Market Status
9.7 Convergence Pharmaceuticals Limited
9.7.1 Convergence Pharmaceuticals Limited Profiles
9.7.2 Convergence Pharmaceuticals Limited Product Portfolio
9.7.3 Convergence Pharmaceuticals Limited Ion Channel Modulators Business Performance
9.7.4 Convergence Pharmaceuticals Limited Ion Channel Modulators Business Development and Market Status
9.8 Cytocentrics AG
9.8.1 Cytocentrics AG Profiles
9.8.2 Cytocentrics AG Product Portfolio
9.8.3 Cytocentrics AG Ion Channel Modulators Business Performance
9.8.4 Cytocentrics AG Ion Channel Modulators Business Development and Market Status
9.9 Evotec AG
9.9.1 Evotec AG Profiles
9.9.2 Evotec AG Product Portfolio
9.9.3 Evotec AG Ion Channel Modulators Business Performance
9.9.4 Evotec AG Ion Channel Modulators Business Development and Market Status
9.10 Flyion GmbH
9.10.1 Flyion GmbH Profiles
9.10.2 Flyion GmbH Product Portfolio
9.10.3 Flyion GmbH Ion Channel Modulators Business Performance
9.10.4 Flyion GmbH Ion Channel Modulators Business Development and Market Status
9.11 GlaxoSmithKline Plc.
9.12 Nanion Technologies GmbH
9.13 NeuroSearch A/S
9.14 Novartis AG
9.15 Parion Sciences, Inc.
9.16 Sanofi
9.17 Targacept, Inc.
9.18 Xention Limited
9.19 Zalicus, Inc.
9.20 Others
10 World Ion Channel Modulators Market Assessment by Players
10.1 Global Ion Channel Modulators Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Ion Channel Modulators Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Ion Channel Modulators Price (USD/Unit) of Players 2014-2020
10.4 Global Ion Channel Modulators Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Ion Channel Modulators Sales Assessment of Players 2014-2020
11.1.2 North America Ion Channel Modulators Revenue Assessment of Players 2014-2020
11.1.3 North America Ion Channel Modulators Price Assessment of Players 2014-2020
11.1.4 North America Ion Channel Modulators Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Ion Channel Modulators Sales Assessment of Players 2014-2020
11.2.2 Europe Ion Channel Modulators Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Ion Channel Modulators Price Assessment of Players 2014-2020
11.2.4 Europe Ion Channel Modulators Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Ion Channel Modulators Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Ion Channel Modulators Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Ion Channel Modulators Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Ion Channel Modulators Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Ion Channel Modulators Sales Assessment of Players 2014-2020
11.4.2 South America Ion Channel Modulators Revenue Assessment of Players 2014-2020
11.4.3 South America Ion Channel Modulators Price Assessment of Players 2014-2020
11.4.4 South America Ion Channel Modulators Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Ion Channel Modulators Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Ion Channel Modulators Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Ion Channel Modulators Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Ion Channel Modulators Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Ion Channel Modulators Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Ion Channel Modulators Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Ion Channel Modulators Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Ion Channel Modulators Sales by Countries/Regions 2014-2020
12.2.2 North America Ion Channel Modulators Revenue by Countries/Regions 2014-2020
12.2.3 North America Ion Channel Modulators Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Ion Channel Modulators Sales by Countries/Regions 2014-2020
12.3.2 Europe Ion Channel Modulators Revenue by Countries/Regions 2014-2020
12.3.3 Europe Ion Channel Modulators Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Ion Channel Modulators Sales by Countries/Regions 2014-2020
12.4.2 South America Ion Channel Modulators Revenue by Countries/Regions 2014-2020
12.4.3 South America Ion Channel Modulators Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Ion Channel Modulators Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Ion Channel Modulators Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Ion Channel Modulators Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Ion Channel Modulators Sales & Revenue Forecast 2021-2026
14.1 World Ion Channel Modulators Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Ion Channel ModulatorsSales and Market Share by Regions
14.1.2 World Ion Channel ModulatorsRevenue and Market Share by Regions
15 Asia Ion Channel Modulators Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Channel Blockers
15.1.2 Channel Openers
15.2 Consumption Forecast by Application, 2021-2026
16 North America Ion Channel Modulators Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Channel Blockers
16.1.2 Channel Openers
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Ion Channel Modulators Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Channel Blockers
17.1.2 Channel Openers
17.2 Consumption Forecast by Application, 2021-2026
18 South America Ion Channel Modulators Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Channel Blockers
18.1.2 Channel Openers
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Ion Channel Modulators Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Channel Blockers
19.1.2 Channel Openers
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Ion Channel Modulators Price (USD/Unit) Trend 2021-2026
20.2 Global Ion Channel Modulators Gross Profit Trend 2021-2026
21 Conclusion
